InMed Pharmaceuticals (INM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
InMed Pharmaceuticals has entered into a Standby Equity Purchase Agreement with Yorkville Advisors, allowing it to sell up to $10 million of its common shares over a 36-month period. This financial strategy provides InMed with flexibility to raise capital as needed, supporting the acceleration of its pharmaceutical programs.
For further insights into INM stock, check out TipRanks’ Stock Analysis page.